 |
|
|
| |
EFFICACY AND SAFETY OF DOLUTEGRAVIR IN TREATMENT-NAIVE PEOPLE
LIVING WITH HIV-1 STRATIFIED BY AGE (>50): META-ANALYSIS OF 48-WEEK RESULTS FROM ARIA, FLAMINGO, SINGLE, AND SPRING-2
|
| |
| |
Glasgow 2020 Oct 5-8 virtual
Reported by Jules Levin
Frank Spinelli,1 Manyu Prakash,2 Jill Slater,1 Mike van der Kolk,3 Niccolo Bassani,4 Richard Grove,5 Brian Wynne,1 Jean van Wyk,2 Andrew Clark2
1ViiV Healthcare, Research Triangle Park, NC, USA; 2ViiV Healthcare, Brentford, UK; 3ViiV Healthcare, Amersfoort, Netherlands; 4Quanticate, Hitchin, UK; 5GlaxoSmithKline, Uxbridge, UK
|
| |
|
|
|
|
|
